Envoy Medical Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 138/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.25.In the medium term, the stock price is expected to trend down.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Envoy Medical Inc's Score
Industry at a Glance
Industry Ranking
138 / 208
Overall Ranking
338 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
8.250
Target Price
+889.92%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Envoy Medical Inc Highlights
StrengthsRisks
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Growing
The company is in a growing phase, with the latest annual income totaling USD 225.00K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 225.00K.
Overvalued
The company’s latest PE is -0.51, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.25M shares, increasing 3.48% quarter-over-quarter.
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Ticker SymbolCOCH
CompanyEnvoy Medical Inc
CEOLucas (Brent T)
Websitehttps://www.envoymedical.com/
FAQs
What is the current price of Envoy Medical Inc (COCH)?
The current price of Envoy Medical Inc (COCH) is 0.733.
What is the symbol of Envoy Medical Inc?
The ticker symbol of Envoy Medical Inc is COCH.
What is the 52-week high of Envoy Medical Inc?
The 52-week high of Envoy Medical Inc is 2.000.
What is the 52-week low of Envoy Medical Inc?
The 52-week low of Envoy Medical Inc is 0.640.
What is the market capitalization of Envoy Medical Inc?
The market capitalization of Envoy Medical Inc is 17.45M.
What is the net income of Envoy Medical Inc?
The net income of Envoy Medical Inc is -27.97M.
Is Envoy Medical Inc (COCH) currently rated as Buy, Hold, or Sell?
According to analysts, Envoy Medical Inc (COCH) has an overall rating of Buy, with a price target of 8.250.
What is the Earnings Per Share (EPS TTM) of Envoy Medical Inc (COCH)?
The Earnings Per Share (EPS TTM) of Envoy Medical Inc (COCH) is -1.426.